GPIIB/IIIA ANTAGONISTS WITH LONG ORAL DURATION

被引：0

作者：

SAMANEN, J ^{[1
]}

ALI, F ^{[1
]}

BARTON, L ^{[1
]}

BONDINELL, W ^{[1
]}

BURGESS, J ^{[1
]}

CALLAHAN, J ^{[1
]}

CALVO, R ^{[1
]}

CHEN, L ^{[1
]}

ERHARD, K ^{[1
]}

HWANG, SM ^{[1
]}

JAKAS, D ^{[1
]}

KEENAN, R ^{[1
]}

KU, T ^{[1
]}

KWON, C ^{[1
]}

LEE, CP ^{[1
]}

MILLER, W ^{[1
]}

NEWLANDER, K ^{[1
]}

NICHOLS, A ^{[1
]}

PARKER, M ^{[1
]}

PEISHOFF, C ^{[1
]}

RHODES, G ^{[1
]}

ROSS, S ^{[1
]}

SIMPSON, R ^{[1
]}

TAKATA, D ^{[1
]}

YELLIN, TO ^{[1
]}

UZSINSKAS, I ^{[1
]}

VENSLAVSKY, J ^{[1
]}

YUAN, CY ^{[1
]}

HUFFMAN, W ^{[1
]}

机构：

[1] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：237 / MEDI

共 50 条

[21] Characterization of ligand induced binding sides on GPIIb/IIIa upon binding of GPIIb/IIIa antagonists using monoclonal antibodies.
McQueney, PA
Bollag, DM
Hartman, GD
Gould, RJ
Bednar, B
CIRCULATION, 1996, 94 (08) : 570 - 570
[22] Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes
O'Connor, FF
Shields, DC
Fitzgerald, A
Cannon, CP
Braunwald, E
Fitzgerald, DJ
BLOOD, 2001, 98 (12) : 3256 - 3260
[23] PLATELET GpIIb/IIIa RECEPTOR ANTAGONISTS IN ANGIOLOGY AND VASCULAR AND ENDOVASCULAR SURGERY
Blanes-Mompo, J. I.
Torres-Blanco, A.
ANGIOLOGIA, 2007, 59 (03): : 207 - 215
[24] Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease
Seitz, Ruediger J.
Siebler, Mario
CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (01) : 29 - 36
[25] Discovery and pharmacological evaluation of new platelet glycoprotein gpIIb/IIIa antagonists
Merlos, M
Rabasseda, X
Silvestre, JS
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (10): : 869 - 880
[26] PLATELET-GPIIB/IIIA ANTAGONISTS - HOW SAFE IS THIS ANTITHROMBOTIC APPROACH
MOUSA, SA
DEGRADO, WF
REILLY, TM
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (03): : 300 - 300
[27] THE INTERACTIONS OF MULTIVALENT FIBRINOGEN RECEPTOR ANTAGONISTS WITH PURIFIED GPIIB/IIIA AND PLATELETS
BEDNAR, B
BEDNAR, RA
CHANG, CT
GAUL, SL
EGBERTSON, MS
HARTMAN, GD
SHAFER, JA
GOULD, RJ
FASEB JOURNAL, 1995, 9 (04): : A838 - A838
[28] A new class of orally active GPIIb-IIIa antagonists.
Steiner, B
Alig, L
Blackburn, B
Bunting, S
Hurzeler, M
Schmitt, M
Weiss, S
Weller, T
BLOOD, 1995, 86 (10) : 351 - 351
[29] UR-3216: A manageable oral GPIIb/IIIa antagonist
Baba, K
Aga, Y
Nakanishi, T
Motoyama, T
Ueno, H
CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (01): : 25 - 40
[30] Ring constrained analogues of β-alanine-containing GPIIb/IIIa receptor antagonists
Sielecki, TM
Wityak, J
Liu, J
Mousa, SA
Thoolen, M
Wexler, RR
Olson, RE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (05) : 449 - 452

← 1 2 3 4 5 →